Etraga
Etraga is a cancer medicine that stops cancer cells from growing and helps the bone marrow make healthy blood cells.
Form
injektiokuiva-aine, suspensiota varten
Strength
25 mg/ml
Active Ingredient
Azacitidine
Manufacturer
STADA Arzneimittel AG
How to Use
Dosage
Your doctor will decide your dose, usually 75 mg per square meter of body surface, based on your general health, height, and weight.
Method
A doctor or nurse will give you this medicine as an injection under the skin in your thigh, stomach, or upper arm. You will receive it daily for one week, followed by a 3-week break, and this cycle is repeated every 4 weeks for at least 6 cycles.
Important
The maximum daily dose is usually 75 mg per square meter of body surface. Your doctor will determine your exact dose.
Possible Side Effects
COMMON
- •Low red blood cells (anemia) causing tiredness and paleness; low white blood cells causing fever and infections; low platelets causing bleeding and bruising.
- •Constipation, diarrhea, nausea, vomiting, stomach pain, loss of appetite, mouth or tongue sores, gum bleeding.
- •Redness, pain, itching, swelling, bruising, or lumps at the injection site.
- •Tiredness, fever, headache, dizziness, difficulty sleeping, muscle aches, weakness, weight loss, chills.
- •Pneumonia (lung infection), urinary tract infection, herpes (cold sores), sepsis (blood infection), oral thrush (white coating in mouth), skin infection (cellulitis), nose and throat infections.
- •Nosebleeds, blood in urine, bleeding under the skin (bruises), bleeding in the stomach or gut, bleeding from hemorrhoids, eye bleeding, internal head bleeding.
- •Shortness of breath, chest pain, cough, throat pain, inflamed lungs.
- •Skin rash, red or purple spots under the skin (bruising).
- •High or low blood pressure, dizziness when standing up.
- •Anxiety, confusion, hair loss, dehydration, low potassium in blood, general feeling of being unwell.
RARE
- •Severe allergic reactions (hypersensitivity).
- •Liver failure.
- •Painful skin sores or raised, painful, purple skin patches (pyoderma gangrenosum); severe skin infection that spreads quickly (necrotizing fasciitis); inflammation of blood vessels in the skin (skin vasculitis).
- •Inflammation around the heart (pericarditis).
- •Tumor lysis syndrome (metabolic complications that can occur during cancer treatment, including changes in blood chemicals that can affect kidney function, heart rhythm, and sometimes cause seizures or death).
- •Severe immune reaction (differentiation syndrome), which can cause fever, cough, breathing difficulties, rash, reduced urination, low blood pressure, swelling in arms or legs, and rapid weight gain.
- •Dry cough, painless swelling in fingertips (clubbing).
- •Tremor.
Important Warnings
- Do not use Etraga if you are allergic to azacitidine or any other ingredients in the medicine.
- Avoid using Etraga if you have advanced liver cancer or are breastfeeding.
- Tell your doctor if you have low blood platelet, red blood cell, or white blood cell counts.
- Discuss with your doctor if you have kidney, liver, heart, or lung disease.
- Etraga should not be used during pregnancy as it may harm the baby. Women who can become pregnant and men who can father children need effective contraception during treatment and for a period after.
Show 1 more warnings
- Do not drive or operate machinery if you feel tired or experience other side effects.